VILIMEKSO SERVISAS - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 2,443,402 | 3,474,969 | 3,910,010 | 4,002,593 | 3,429,026 | 4,081,222 | 3,579,690 | 3,234,561 |
| Profit before tax | 164,457 | 346,069 | 472,999 | 442,327 | 240,782 | 476,055 | 354,703 | 283,611 |
| Net profit | 139,053 | 290,512 | 399,859 | 371,724 | 200,682 | 404,832 | 302,027 | 230,720 |
| Equity | 1,478,881 | 1,769,393 | 2,169,252 | 2,083,527 | 2,284,209 | 2,732,010 | 2,984,037 | 2,814,757 |
| Liabilities | 737,195 | 1,201,079 | 1,739,041 | 1,721,468 | 2,764,515 | 2,411,288 | 2,028,943 | 1,673,966 |
| Non-current assets | 941,011 | 961,311 | 1,222,679 | 890,676 | 2,467,875 | 2,825,837 | 2,733,540 | 2,927,093 |
| Current assets | 1,271,695 | 2,005,120 | 2,682,868 | 2,911,825 | 2,574,720 | 2,324,163 | 2,317,918 | 1,653,038 |
| Total assets | 2,212,706 | 2,966,431 | 3,905,547 | 3,802,501 | 5,042,595 | 5,150,000 | 5,051,458 | 4,580,131 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 851,426 | 792,185 | 637,407 |
| Social insurance contributions | - | - | - | - | - | 128,907 | 132,615 | 121,279 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -9.1% | +42.2% | +12.5% | +2.4% | -14.3% | +19.0% | -12.3% | -9.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | 6.3% | 9.8% | 10.2% | 9.8% | 4.0% | 7.9% | 6.0% | 5.0% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | 9.4% | 16.4% | 18.4% | 17.8% | 8.8% | 14.8% | 10.1% | 8.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | 5.7% | 8.4% | 10.2% | 9.3% | 5.9% | 9.9% | 8.4% | 7.1% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | 6.7% | 10.0% | 12.1% | 11.1% | 7.0% | 11.7% | 9.9% | 8.8% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.5 | 0.7 | 0.8 | 0.8 | 1.2 | 0.9 | 0.7 | 0.6 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 119,190 | 164,821 | 223,429 | 240,155 | 214,314 | 221,604 | 211,607 | 229,674 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
VILIMEKSO SERVISAS - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2025-08-28 | 2025-08-29 | 10.39 |
| 2025-08-19 | 2025-08-24 | 10.39 |
| 2025-07-24 | 2025-08-11 | 10.39 |
| 2025-06-17 | 2025-06-19 | 9616.26 |
VILIMEKSO SERVISAS - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2026-02-03 | 2026-02-16 | 0.24 |
| 2025-05-29 | 2025-06-05 | 11.2 |
| 2025-05-20 | 2025-05-20 | 609.0 |
| 2025-05-19 | 2025-05-19 | 10010.0 |
| 2025-05-17 | 2025-05-18 | 10012.0 |
| 2024-12-19 | 2024-12-19 | 2300.2 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
VILIMEKSO SERVISAS, UAB (code 123055213) is a Private Limited Liability Company engaged in the wholesale of pharmaceutical and medical goods. In the latest financial year 2025, revenue amounted to €3.23M and net profit to €230.7K, resulting in a profit margin of 7.1%. Performance weakened over the period, with revenue falling by 9.6% year on year and by 20.8% over two years, from €4.08M in 2023 to €3.58M in 2024 and then to €3.23M in 2025. Net profit also declined from €404.8K in 2023 to €302.0K in 2024 and €230.7K in 2025. At the end of 2025, total assets stood at €4.58M, equity at €2.81M and liabilities at €1.67M. The equity ratio was 61.5% and debt-to-equity 0.59, indicating a relatively balanced capital structure. Asset turnover was 0.71x, while return on equity reached 8.2% and return on assets 5.0%. Revenue per employee was €231.0K and profit per employee €16.5K.